Risk factors for positive follow‐up blood cultures in Gram‐negative bacteremia among immunocompromised patients with neutropenia
Transplant Infectious Disease · 2024
DOI: 10.1111/tid.14203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Nischal Ranganath und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Gram-Negative Bacterial Infections, Bacteremia, Neutropenia, Sepsis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
Introduction
Gram‐negative bacillary bloodstream infection (GN‐BSI) is a frequent clinical challenge among immunocompromised hosts and is associated with a high mortality. The utility of follow‐up blood cultures (FUBCs) for GN‐BSI in this population, particularly in the setting of neutropenia, is poorly defined.
Methods
We conducted a single‐center, retrospective cohort study between the period of July 2018 and April 2022 to investigate the utility of FUBCs and delineate risk factors for positive cultures among neutropenic patients with monomicrobial GN‐BSI. Univariate logistic regression was performed to assess risk factors associated with positive FUBCs.
Results
Of 206 patients, 98% had FUBCs performed, and 9% were positive. Risk factors for positive FUBCs included multidrug‐resistant GN infection (OR 3.26; 95% confidence interval [CI] 1.22–8.72) and vascular catheter source (OR 4.82; CI 1.76–13.17). Among patients lacking these risk factors, the prevalence of positive FUBCs was low (2.8%) and the negative predictive value was 92%. Those with positive and negative FUBCs had similar rates of all‐cause mortality (16.7% vs. 16.6%; p = .942) and microbiologic relapse (11.1% vs. 6.0%; p = .401) within 90‐days of treatment completion. However, positive FUBCs were associated with prolonged hospitalization and longer duration of antimicrobial therapy.
Conclusion
Positive FUBCs were infrequent in neutropenic patients with GN‐BSI, and their occurrence did not significantly impact mortality or microbiologic relapse. Risk factors for positive FUBCs included multidrug resistant Gram‐negative infection and vascular catheter source. Prospective studies will be necessary to elucidate the benefits and risks of FUBCs when managing GN‐BSI in patients with underlying immune compromise. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Nischal Ranganath, Zachary A Yetmar, Aaron J Tande, Aditya S Shah
Förderung
- NCATS NIH HHS
- National Center for Advancing Translational Sciences
Zitieren
APA
Ranganath, N., Yetmar, Z. A., Saleh, O. A., Tande, A. J., & Shah, A. S. (2024). Risk factors for positive follow‐up blood cultures in Gram‐negative bacteremia among immunocompromised patients with neutropenia. Transplant Infectious Disease. https://doi.org/10.1111/tid.14203
Vancouver
Ranganath N, Yetmar ZA, Saleh OA, Tande AJ, Shah AS. Risk factors for positive follow‐up blood cultures in Gram‐negative bacteremia among immunocompromised patients with neutropenia. Transplant Infectious Disease. 2024. doi:10.1111/tid.14203
BibTeX
@article{Ranganath2024,
author = {Ranganath, Nischal and Yetmar, Zachary A and Saleh, Omar Abu and Tande, Aaron J and Shah, Aditya S},
title = {Risk factors for positive follow‐up blood cultures in Gram‐negative bacteremia among immunocompromised patients with neutropenia},
journal = {Transplant Infectious Disease},
year = {2024},
doi = {10.1111/tid.14203}
}
EUVIMED